๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A multicenter, double-blind, randomized safety and efficacy study of two dose levels of taliglucerase alfa in pediatric patients with Gaucher disease

โœ Scribed by Zimran, Ari; Gonzalez-Rodriguez, Derlis Emilio; Abrahamov, Aya; Elstein, Deborah; Paz, Alona; Brill-Almon, Einat; Chertkoff, Raul


Book ID
122046576
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
60 KB
Volume
108
Category
Article
ISSN
1096-7192

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Efficacy and safety of high-dose pravast
โœ James H. Lewis; Mary Ellen Mortensen; Steven Zweig; Mary Jean Fusco; Jeffrey R. ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 148 KB ๐Ÿ‘ 2 views

The hepatotoxic potential of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in patients with underlying chronic liver disease remains controversial. We performed a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial that compared pravastatin (80 mg) to a place